In ₹ Crore except Per Share Latest Annual | SAILIFE FY26 | SYNGENE FY26 | DIVISLAB FY26 | PPLPHARMA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 95.70× | ◆ 48.79× | 97.31× | — | 73.05× +31% | |
| P/B | 13.57× | ◆ 3.20× | 14.89× | 3.45× | 3.45× +294% | |
| EV/EBITDA | 53.35× | ◆ 16.11× | 72.47× | 35.05× | 35.05× +52% | |
| Market Cap | ₹33,705 Cr | ₹15,471 Cr | ₹2.49L Cr | ₹28,134 Cr | ₹28,134 Cr +20% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 5.40% | ◆ 10.78% | 7.79% | 7.79% | |
| Revenue CAGR 5Y | — | ◆ 11.35% | 8.67% | — | 10.01% | |
| Net Income CAGR 3Y | — | -11.98% | ◆ 12.09% | — | 0.05% | |
| Revenue YoY (latest Q) | 11.66% | -15.84% | ◆ 27.80% | 17.39% | 17.39% -33% | |
| Net Income YoY (latest Q) | 21.22% | -110.38% | ◆ 65.50% | 15.07% | 15.07% +41% | |
| Profitability | ||||||
| EBITDA Margin | 28.79% | 24.57% | ◆ 32.59% | 10.39% | 24.57% +17% | |
| Net Income Margin | 15.91% | 8.47% | ◆ 24.32% | -3.68% | 8.47% +88% | |
| Return on Common Equity | 14.05% | 6.54% | ◆ 15.32% | -3.99% | 6.54% +115% | |
| Return on Capital Employed | ◆ 16.63% | 8.46% | 16.55% | 0.68% | 8.46% +97% | |
| Return on Assets | 9.62% | 4.49% | ◆ 12.82% | -1.81% | 4.49% +114% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.04× | ◆ 0.00× | 0.00× | 0.67× | 0.00× | |
| Interest Coverage | 11.83× | 9.54× | ◆ 129.48× | 0.27× | 9.54× +24% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,192 Cr | ₹3,739 Cr | ₹10,560 Cr | ₹8,869 Cr | ₹8,869 Cr -75% | |
| Net Income | ₹349 Cr | ₹317 Cr | ₹2,568 Cr | −₹326 Cr | ₹317 Cr +10% | |
| Total Assets | ₹3,626 Cr | ₹7,055 Cr | ₹20,033 Cr | ₹17,965 Cr | ₹17,965 Cr -80% | |
| EPS | ₹16.63 | ₹7.87 | ₹96.75 | ₹-2.46 | ₹7.87 +111% | |
| Book Value per Share | ₹117.28 | ₹120.11 | ₹632.49 | ₹61.5 | ₹120.11 -2% | |